Literature DB >> 507078

Predicting warfarin maintenance dosage based on initial response.

D R Miller, M A Brown.   

Abstract

The relationship between initial response to warfarin sodium, as measured by prothrombin time, and warfarin maintenance dose was studied. Hospital patients received 10 mg of warfarin sodium daily until the prothrombin ratio (patient's prothrombin time/control) was 1.5 to 2.5. Patients subsequently were maintained at that warfarin dosage which maintained prothrombin ratios within this range. Twenty-two patients completed the study. A correlation was found between maintenance dose and the logarithm of the prothrombin ratio on the third day after initiating warfarin therapy (p less than 0.01, r = -0.74). There was no relationship between maintenance dose and the number of days needed to reach therapeutic response. Patients with baseline prothrombin ratios of less than one took significantly longer to reach therapeutic response than did patients with baselines of greater than one (p less than 0.01y. A simple yet scientific approach to determining warfarin maintenance dosage would seem to be feasible. The correlation found between maintenance dose and prothrombin ratio in this study would have to be applied cautiously and only after further validation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 507078

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  7 in total

1.  A simple technique for predicting maintenance dosage of warfarin--is it better than empirical dosing?

Authors:  L Ovesen; S Lyduch; P Ott
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing.

Authors:  R H White; R Hong; A P Venook; M M Daschbach; W Murray; D R Mungall; R W Coleman
Journal:  J Gen Intern Med       Date:  1987 May-Jun       Impact factor: 5.128

3.  Flexible induction dose regimen for warfarin and prediction of maintenance dose.

Authors:  A Fennerty; J Dolben; P Thomas; G Backhouse; D P Bentley; I A Campbell; P A Routledge
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-28

4.  Warfarin dosage requirements: prospective clinical trial of a method for prediction from the response to a single dose.

Authors:  D M Jupe; G M Peterson; R L Coleman; S McLean
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

Review 5.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

6.  Theophylline and warfarin interaction studies with grepafloxacin.

Authors:  C Efthymiopoulos; S L Bramer; A Maroli; B Blum
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.